What drove the ALRPD.PA stock move pre-market on 12 Feb 2026?

The pre-market rise to **€11.50** was driven by a high-volume session of **48,792** shares. The move followed buying interest that lifted price above the 50-day average and coincided with bullish technical readings. No single news release was confirmed at time of writing.

How does Meyka AI rate ALRPD.PA stock?

Meyka AI rates ALRPD.PA **62.23/100 (Grade B)** with a **HOLD** suggestion. The grade blends sector and benchmark comparisons, financial growth, key metrics, forecasts, and analyst sentiment. Grades are informational and not investment advice.

What price targets and forecast does Meyka AI provide for ALRPD.PA stock?

Meyka AI's forecast model projects a **monthly price of €7.20**, implying **-37.39%** from **€11.50**. Scenario targets include a conservative **€6.00** and a bullish **€20.00**. Forecasts are model-based projections and not guarantees.

What are the main risks for ALRPD.PA stock investors?

Main risks include negative earnings (**EPS -22.85**), thin market cap **€5.18M**, low liquidity versus large caps, and stretched valuation ratios. Regulatory outcomes or weak sales would amplify downside on EURONEXT.

EU Stocks

ALRPD.PA Rapid Nutrition (EURONEXT) 13.64% pre-market 12 Feb 2026: rising volume

ByHuzaifa Zahoor February 12, 2026

The ALRPD.PA stock opened the pre-market session higher after a strong intraday move, trading at €11.50, up 13.64% on a volume spike to 48,792 shares. Rapid Nutrition (ALRPD.PA) is listed on EURONEXT and the move follows heavy relative volume versus the 19,419 average. Investors should note the gap from the 50-day average of €4.53 and the 200-day average of €5.22, which frames this rally against a recent recovery trend in Europe’s healthcare names.